# LUMENS-1 Canada Early Feasibility Study Clinical Investigation Plan

> **NCT07259018** · NA · NOT_YET_RECRUITING · sponsor: **LuSeed Vascular LTD.** · enrollment: 10 (estimated)

## Conditions studied

- Aneurysm Cerebral
- Bifurcation
- Unruptured Intracranial Aneurysm
- Saccular Aneurysm
- Brain Aneurysm

## Interventions

- **DEVICE:** LuSeed Aneurysm Embolization System

## Key facts

- **NCT ID:** NCT07259018
- **Lead sponsor:** LuSeed Vascular LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-12
- **Final completion:** 2028-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07259018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07259018, "LUMENS-1 Canada Early Feasibility Study Clinical Investigation Plan". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07259018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*